IP Verse
Top Law Firms
Unified Patent Court
Trending Technologies
Blogs
Contact Us
Toggle menu
Amgen, Inc. opposition analysis
COMPANY ANALYSIS
Latest patents of Amgen, Inc. opposed by its competitors
Patent:
EP2301961
Grant Date:
Dec 13, 2023
Title:
Sclerostin Epitopes
Oppositions:
1
Patent:
EP2345668
Grant Date:
Sep 22, 2021
Title:
Sclerostin Epitopes
Oppositions:
1
Latest patents of Amgen, Inc. opposed by its competitors
Patent Number
Grant Date
Title
Total Oppositions
EP2301961
Dec 13, 2023
Sclerostin Epitopes
1
EP2345668
Sep 22, 2021
Sclerostin Epitopes
1
Competitors of Amgen, Inc.
JAMES POOLE LIMITED
Want to track Amgen, Inc.?
Feel free to send us a message here and we will get back to you
Name
Email
Message
Let's get in touch